What is SubjectWell?
SubjectWell operates as a specialized marketplace dedicated to clinical trial patient recruitment. By raising awareness of clinical research among the general population, the platform provides patients with greater autonomy and easier access to cutting-edge medical treatments. The company serves as a vital intermediary, ensuring that clinical trials are populated efficiently while maintaining high standards of patient engagement and choice. Its market position is defined by its ability to reduce the friction typically associated with trial enrollment, thereby accelerating the timeline for drug development and medical innovation.
How much funding has SubjectWell raised?
SubjectWell has raised a total of $45.9M across 4 funding rounds:
Series A
$10M
Debt
$350K
Debt
$542K
Series B
$35M
Series A (2019): $10M with participation from Geekdom Fund, Healthy Ventures, and Windham Venture Partners
Debt (2020): $350K led by PPP
Debt (2021): $542K supported by PPP
Series B (2022): $35M featuring Geekdom Fund, Venture Asset Management, Healthy Ventures, Windham Venture Partners, and Bertelsmann SE
Key Investors in SubjectWell
Geekdom Fund
Geekdom Fund is a venture capital firm dedicated to connecting entrepreneurs with investors, providing significant support and resources to portfolio companies with a focus on high-growth potential.
Healthy Ventures
Healthy Ventures is a purpose-built, early-stage venture investor focused on health tech, aiming to support the scaling and diversification of healthcare technologies.
Windham Venture Partners
Windham Venture Partners is a New York City based venture capital firm focused on healthcare, with particular emphasis on medical technology and digital health.
What's next for SubjectWell?
With the successful closure of its latest financing round, SubjectWell is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to leverage this capital to enhance its digital infrastructure, expand its reach into new therapeutic areas, and deepen its integration with major healthcare providers and research organizations. As the clinical trial landscape becomes increasingly competitive, SubjectWell's focus on patient-centric recruitment will likely serve as a key differentiator, enabling the firm to capture a larger share of the multi-billion dollar clinical research market. Future initiatives will likely prioritize the scaling of its proprietary technology to meet the complex demands of global pharmaceutical partners.
See full SubjectWell company page
